Pharmaceuticals
Bioniche Pharma Launches Enlon(R) and Enlon-Plus(R) Injection
Published in Drug Week, May 29th, 2009
"The acquisition and launch of Enlon(R) represent Bioniche's continued growth and a commitment to bringing this important therapy back to market and into the hands of health care professionals," said Steve Thornton, CEO, Bioniche Pharma.
Bioniche purchased the rights and certain assets related to the Enlon(R) product line from Baxter Corporation, which discontinued Enlon(R) in February 2008. According to IMS data,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2009-05-29)
More Articles from Drug Week
- American Associates, Ben-Gurion University of the Negev
Ben-Gurion U of the Negev study demonstrates link between appetite and elderly mortality - American Cancer Society
Review finds conflicts of interest in many cancer studies - American Dietetic Association
ADA releases position paper on obesity, reproduction and pregnancy outcomes - BioMed Central
Improving education may cut smoking in youth - BioMed Central
Sodium bicarbonate reduces incidence of contrast-induced nephropathy - Group Health Cooperative Center for Health Studies
Acupuncture eases chronic low back pain in SPINE trial - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
